ClinicalTrials.gg
RecruitingNCT07722247Updated Aug 18, 2026

Corneal Biomechanics and Surgically Induced Astigmatism in Pseudoexfoliation Syndrome

An observational study in Pseudoexfoliation Syndrome, Cataract and Astigmatism, sponsored by Kata Culina. Recruiting at 1 site in Croatia. Open to participants aged 50 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by Kata Culina · Observational

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
50 Years to 85 Years
Sex
All
01

Study summary

This prospective study aims to evaluate the influence of corneal biomechanical properties on surgically induced astigmatism following standard phacoemulsification cataract surgery in patients with pseudoexfoliation syndrome compared with patients without pseudoexfoliation. Corneal hysteresis (CH), corneal resistance factor (CRF) and corneal astigmatism will be measured before surgery and at postoperative follow-up visits. The relationship between changes in corneal biomechanics and surgically induced astigmatism will be analyzed.

Read the detailed description

Pseudoexfoliation syndrome is associated with structural alterations of the anterior segment and may affect the biomechanical behavior of the cornea. Corneal hysteresis (CH) and corneal resistance factor (CRF), measured using the Ocular Response Analyzer, are indicators of corneal biomechanical properties and may influence the corneal response to cataract surgery and magnitude of surgically induced astigmatism.

This prospective, single-center observational study will include approximately 70 patients undergoing routine phacoemulsification cataract surgery. Participants will be allocated into two groups according to the presence or absence of pseudoexfoliation syndrome.

CH, CRF and corneal astigmatism will be measured preoperatively and postoperatively at scheduled follow-up visits at postoperative day 1, 7 and 30. Surgically induced astigmatism will be calculated from keratometric measurements.

The primary objective of the study is to determine whether correlations exist between corneal biomechanical properties (CH and CRF) and surgically induced astigmatism in patients with pseudoexfoliation syndrome and to compare these correlations with those observed in patients without pseudoexfoliation syndrome.

02

Conditions studied

  • Pseudoexfoliation Syndrome
  • Cataract
  • Astigmatism

Keywords

  • corneal biomechanics
  • corneal hysteresis
  • corneal resistence factor
  • cataract surgery
  • pseudoexfoliation syndrome
  • surgically induced astigmatism
03

In context

Exfoliation Syndrome

72 studies on the registry are indexed under Exfoliation Syndrome; 20 are open to participants now.

This study's planned enrollment of 70 is close to the median of 76 across 38 observational studies indexed under Exfoliation Syndrome.

Browse Exfoliation Syndrome studies →

Lead sponsor

Kata Culina is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of adult patients with age-related cataract scheduled for routine phacoemulsification cataract surgery at Eye clinic Medic Jukic. Participants will include patients with pseudoexfoliation syndrome and an a control group without pseudoexfoliation syndrome of similar age range. Consecutive eligible patients who meet the inclusion criteria and provide written informed consent will be enrolled.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 50-85 years
  • Age-related cataract scheduled for standard phacoemulsification cataract surgery with intraocular lens implantation
  • Presence of pseudoexfoliation syndrome (PEX group) or absence of pseudoexfoliation syndrome (control group)
  • Ability to provide written
  • Willingness to attend all scheduled postoperative follow-up visits

Exclusion criteria

Exclusion Criteria:

  • Previous ocular surgery in the study eye
  • Corneal diseases or abnormalities that may affect corneal biomechanical measurements or keratometry
  • Glaucoma and ocular hypertension
  • Ocular trauma or active ocular inflammation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Pseudoexfoliation syndrome

    Patients with pseudoexfoliation syndrome undergoing standard phacoemulsification cataract surgery

    Procedure: phacoemulsification cataract surgery

  • Control group

    Patients without pseudoexfoliation syndrome undergoing standard phacoemulsification cataract surgery

    Procedure: phacoemulsification cataract surgery

Interventions

  • Procedurephacoemulsification cataract surgery

    Standard phacoemulsification cataract surgery with intraocular lens implantation performed according to routine clinical practice.

06

What researchers measure

Primary outcomes

  1. Correlation between corneal biomechanical properties and surgically induced astigmatism

    To evaluate the correlation between corneal hysteresis (CH), corneal resistance factor (CRF), and surgically induced astigmatism (SIA) after phacoemulsification cataract surgery in patients with pseudoexfoliation syndrome and compare the findings with a control group.

    Time frame: Preoperative, postoperative day 1, postoperative day 7, and postoperative day 30.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07722247
Lead sponsor
Kata Culina
Responsible party
Kata Culina (Principal investigator, Ophthalmologist, Eye Clinic Medic Zuljan Jukic) — Sponsor-investigator
First posted
Jul 23, 2026
Start date
Jul 20, 2026
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Aug 18, 2026

Study contacts

Kata Culina, MD, PhD
Contact
kculina@yahoo.com
+38598615556
Andela Jukic, MD, PhD
Contact
andela.jukic@yahoo.com
+385981733912

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion